Thromb Haemost 1963; 10(02): 332-349
DOI: 10.1055/s-0038-1654788
Originalarbeiten — Original Article — Travaux Originaux
Schattauer GmbH

Prothrombin Levels in Serum[*]

John A Penner**
1   Department of Internal Medicine (Simpson Memorial Institute) The University of Michigan, Ann Arbor, Michigan
› Author Affiliations
This work was supported by a grant from the Michigan Heart Association.
Further Information

Publication History

Publication Date:
22 June 2018 (online)

Summary

Prothrombin has been studied in clotting blood and plasma using the modified 2-stage prothrombin assay of Ware and Seegers. The quantity as well as the rate of prothrombin activation has been determined in whole blood and recalcified plasma obtained from 20 normal individuals. A thorough evaluation was made of the techniques used and the effect of variables such as temperature, surface contact, calcium, platelet concentration, and pH.

A relatively constant rate of prothrombin activation was observed in clotting blood and recalcified frozen-thawed plasma.

The results of this study confirm previous investigations of Langdell, Graham, and Brinkhous using the prothrombin utilization assay. In normal blood, the plasma procoagulants are found to be present in relative excess in comparison to platelet Factor 3. The lack of available platelet factor contained in the intact platelets effectively limits prothrombin activation. Disruption or alteration of the platelets permits the release of large quantities of platelet Factor 3 and produces a marked increase in the rate of prothrombin activation.

Glass contact was observed to increase prothrombin activation in blood and plasma.

The use of plasma prothrombin as a substrate for evaluation of procoagulant activity is discussed and advantages of this system of assay are emphasized.

* Portions of this paper were presented to the X Annual Blood Symposium, January 1961, Detroit, Michigan.


** Research Associate, Simpson Memorial Institute Assistant Professor of Internal Medicine, Established Investigator, American Heart Association.


 
  • References

  • 1 Penner J. A, Seegers W. H. Activation of Prothrombin. Amer. J. Physiol. 186: 343 1956;
  • 2 Quick A. J. The Determination of Prothrombin. Flynn J. E. ed. Blood Clotting and Allied Problems. Trans. 1st Macy Conf. 170 Jos. Macy Jr. Found; Packanack Lake, N.J: 1948
  • 3 Owren P. A. New Clotting Factors in. Flynn J. E. ed. Blood Clotting and Allied Problems. Trans. 5th Macy Conf. 92 Jos. Macy Jr. Found; Packanack Lake, N.J: 1952
  • 4 Quick A. J, Favre-Gilly J. E. The Prothrombin Consumption Test; Its Clinical and Theoretic Implications. Blood 04: 1281 1949;
  • 5 Warner E. P, Brinkhous K. M, Smith H. P. The Titration of Prothrombin in Certain Plasmas. Arch. Path. 18: 587 1934;
  • 6 Ware A. G, Seegers W. H. Two-Stage Procedure for the Quantitative Determination of Prothrombin Concentration. Amer. J. clin. Path. 19: 471 1949;
  • 7 Sternberger L. A. The Stabilization of Thrombin in Plasma: Development of a Simple Two-Stage Method for the Determination of Prothrombin. Brit. J. exp. Path. 28: 168 1947;
  • 8 DeVries A, Herz N, Heiman-Hollander E. Observations on Prothrombin Consumption During Clotting of Normal Blood in Glass. Acta. med. scand. 138: 219 1950;
  • 9 Graham J. B, Langdell R. D, Brinkhous K. M. Estimation of the Rate of Prothrombin Utilization. In: Tocantins L. M. ed. Coagulation of the Blood. 117 Grune & Stratton; New York: 1955
  • 10 Seegers W. H. Unpublished data.
  • 11 Mertz E. T, Owen C. A. Buffer Solutions of Imidazole. In: Tocantins L. M. ed. Coagulation of the Blood. 11 Grune & Stratton; New York: 1955
  • 12 Brecher G, Cronkite E. P. Morphology and Enumeration of Human Blood Platelets. J. appl. Physiol. 03: 365 1950;
  • 13 Tocantins L. M. ed. Removal and Application of Silicone. In: Coagulation of the Blood. 8 Grune & Stratton; New York: 1955
  • 14 Langdell R. D, Graham J. B, Brinkhous K. M. Prothrombin Utilization During Clotting: Comparison of Results with the Two-Stage and One-Stage Methods. Proc. Soc. exp. Biol. (N. Y) 74: 424 1950;
  • 15 Wagner R. H, Graham J. B, Penick G. D, Brinkhous K. M. Estimation of Prothrombin by the Two-Stage Method. In: Tocantins L. M. ed. Coagulation of the Blood. 105 Grune & Stratton; New York: 1955
  • 16 Johnston Jr. C. L, Ferguson J. H. Some Factors Concerned with the Two-Stage Plasma Prothrombin Assay. J. Lab. clin. Med. 37: 294 1951;
  • 17 Buckwalter J. A, Blythe W. B, Brinkhous K. M. Effect of Blood Platelets on Prothrombin Utilization of Dog and Human Plasma. Amer. J. Physiol. 159: 316 1949;
  • 18 Seegers W. H. Nature of the Blood Coagulation Mechanisms. In: Seegers W. H. Ass.: Blood Coagulation: Collected Papers by, reprinted from Thrombosis and Embolism, Basel 1954, 1st Internat’l. Conf..
  • 19 Jaques L. B, Fidler E, Feldsted E. T, MacDonald A. G. Silicones and Blood Coagulation. Canad. med. Ass. J. 55: 26 1946;
  • 20 Brinkhous K. M. A Study of the Clotting Defect in Hemophilia. Amer. J. med. Sci. 198: 509 1939;
  • 21 Patton T. B, Ware A. G, Seegers W. H. Clotting of Plasma and Silicone Surfaces. Blood 03: 565 1948;
  • 22 Tocantins L. M. ed. Introductory Exercises. In: Coagulation of the Blood. 13-16 Grune &: Stratton; New York: 1955
  • 23 Dick F. W, Jackson D. P, Conley C. L. Surface as a Quantitative Factor in Prothrombin Utilization. J. clin. Invest 33: 1423 1954;
  • 24 Ratnoff O. D, Dane E. W, Mallell D. L. Studies on the Action of Hageman Factor. J. clin. Invest 40: 803 1961;
  • 25 Quick A. J. Influence of Erythrocytes on the Coagulation of Blood. Amer. J. med. Sci. 239: 101 1960;